Stock 300636 JIANGXI SYNERGY PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Jiangxi Synergy Pharmaceutical Co., Ltd.

Equities

300636

CNE100002P83

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
10.04 CNY +1.72% Intraday chart for Jiangxi Synergy Pharmaceutical Co., Ltd. -2.90% -4.74%
05-20 Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Board Appointments CI
05-20 Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Board Appointments
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2023
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jiangxi Synergy Pharmaceutical Co., Ltd.(XSEC:300636) added to S&P Global BMI Index
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 24 May 2023
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year 2022
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. announced that it expects to receive CNY 1.1 billion in funding
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 05 July 2022
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Dividend for 2021
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Proposes Final Dividend for 2021
CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300636 Stock
  4. News Jiangxi Synergy Pharmaceutical Co., Ltd.